期刊文献+

内分泌激素受体对再生障碍性贫血的影响

Effects of Endocrine Hormone Receptors on Patients with Aplastic Anemia
下载PDF
导出
摘要 目的:探讨糖皮质激素受体(glucocorticoid receptor,GR)、雄激素受体(androgen receptor,AR)表达对再生障碍性贫血(aplastic anemia,AA)影响。方法:利用酶联免疫吸附试验(ELISA)法检测急性再生障碍性贫血(acute aplastic anemia,AAA)、慢性再生障碍性贫血(chronic aplastic anemia,CAA)以及对照组的外周血单个核细胞胞浆和胞核内AR、GR阳性表达水平。结果:与对照组相比,AAA组、CAA组的AR、GR显著低于对照组(P<0.05);AAA组与CAA组相比,AAA组AR、GR阳性水平显著高于CAA组(P<0.05)。结论:AA患者的AR、GR表达水平下降,提示AA的发病与受体水平密切相关。 Objective To evaluate the effects of expressions of androgen receptor(AR) and glucocorticoid receptor(GR) on patients with aplastic anemia(AA). Methods ELISA was used to detect the positive expression levels of endocrine hormone receptors in peripheral blood mononuclearcells of patients with chronic aplastic anemia(CAA), acute aplastic anemia(AAA) and the control group. Results The expression levels of glucocorticoid receptor and androgen receptor of patients with AAA were significantly higher than those of patients with CAA. And the expression levels of AR and GR in AAA and CAA were both lower than those of the control group. Conclusion The abnormal expression of endocrine hormone receptor may play a major role in patients with aplastic anemia.
出处 《深圳中西医结合杂志》 2013年第5期271-273,278,共4页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
基金 浙江省中医药重大疾病科技创新平台科研专项(2009ZDJB01) 2011年浙江省科技厅创新团队(2011R09042-02)
关键词 再生障碍性贫血 糖皮质激素受体 雄激素受体 Chronic aplastic anemia Acute aplastic anemia Androgen receptor Glucocorticoid receptor
  • 引文网络
  • 相关文献

参考文献6

  • 1Khetawat G, Faraday N, Nealen ML, et al. Human megakaryocytes and platelets contain the estrogen receptor β and androgen receptor (AR): testosterone regulates AR expression [J]. Blood, 2000, 95(7):2289-2296.
  • 2司月英,杨朴,高保明.再生障碍性贫血患者糖皮质激素受体及糖皮质激素变化的研究[J].河南医药信息,2001,9(8):26-26. 被引量:3
  • 3Kariagina A, Zonis S, Afkhami M, et al. Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis [J]. American Journal of Physiology-Endocrinology And Metabolism, 2005, 289(5):E857-863.
  • 4田永军,胡慧萍,刘建梅,孙汉英.156例再生障碍性贫血临床分析[J].实用诊断与治疗杂志,2007,21(6):466-468. 被引量:14
  • 5Coviello AD, Kaplan B, Lakshman KM, et al. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men [J]. Journal of Clinical Endocrinology & Metabolism, 2008, 93(3):914-919.
  • 6Frickhofen N, Heimpel H, Kaltwasser JP, et al. Antithymocyte globulin with or without cyclosporinA: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia [J]. Blood, 2003, 101(4):1236-1242.

二级参考文献10

  • 1付蓉.免疫相关性全血细胞减少症的诊断及治疗[J].中国实用内科杂志,2006,26(4):492-496. 被引量:23
  • 2曾慧,何广胜,傅蓉,吴德沛,苗瞄,王秀丽,常伟荣,孙爱宁,金正明.免疫相关性全血细胞减少症患者骨髓Th细胞比例及功能变化[J].江苏医药,2006,32(5):401-403. 被引量:20
  • 3邵宗鸿,袁烨.再生障碍性贫血免疫发病机制及免疫治疗[J].中国实用内科杂志:临床前沿版,2006,26(2):252-255. 被引量:83
  • 4第四届全国再生障碍性贫血学术会议.再生障碍性贫血诊断标准[J].中华血液学杂志,1987,(8).
  • 5田英 徐仁宝.人周围血白细胞糖皮质激素受体的测定[J].中华核医学杂志,1983,1:27-28.
  • 6Young N S,Brown K E,Lu J,et al. Analysis of T cell repertoire in hepatitis-asso ciated aplastic anemia[J]. Blood,2004,103(10): 4588-4593.
  • 7Rosenfeld S,Follmann D,Nunez O,et al. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome [J]. JAMA, 2003, 289(9): 1130-1135.
  • 8Zeng W, Kajigaya S ,Chen G ,et al. Transcript profile of CD4^+ and CD8^+ T cells from the bone marrow of acquired aplastic anemia patients[J]. Exp Hematol,2004,32(9):806-814.
  • 9Mao P, Wang S, Wang S,et al. Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti- lymphocyte globulin and cyclophosphamide as conditioning therapy[J]. Bone Marrow Transplant,2004,33 (1) : 33-38.
  • 10Frickhofen N,Heimpel H, Kaltwasser J P,et al. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia [J]. Blood, 2003,101 (4) : 1236-1241.

共引文献15

;
使用帮助 返回顶部